View More View Less
  • 1 Semmelweis Egyetem, Általános Orvostudományi Kar I. Belgyógyászati Klinika Budapest Korányi S. u. 2/a 1083
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $1,070.00

A CYP3A7-enzim részt vesz a dehidroepiandroszteron-szulfát metabolizációjában. Kimutatták, hogy CYP3A7*1C-mutáció esetén férfiakban alacsonyabb a dehidroepiandroszteron-szulfát-szint, és ismert az is, hogy a dehidroepiandroszteron-szulfát-koncentráció csökkenése csontritkuláshoz vezethet. Célkitűzés: A szerzők a CYP3A7*1C-polimorfizmus, a dehidroepiandroszteron-szulfát-szérumszint és a csont ásványanyag-tartalmának együttes vizsgálatát tűzték ki célul, 319 posztmenopauzás nőben. Eredmények: A homozigóta CYP3A7*1C-genotípus esetén a vad típushoz képest szignifikánsan alacsonyabb lumbális gerinccsontdenzitást tapasztaltak (homozigóta mutáns T-score: –3,27 ± 1,02, vs vad típus: –1,35 ± 1,53; p = 0,041). Szignifikáns maradt a kapcsolat a menopauzális kor, szérum-dehidroepiandroszteron-szulfát-szint, az alkoholfogyasztás, a korábbi szteroidkezelés, dohányzás és megelőző csonttörés figyelembevétele után is. Nem volt viszont összefüggés a CYP3A7-genotípus és a dehidroepiandroszteron-szulfát-koncentráció között. Következtetés: A CYP3A7 polimorfizmusa a lumbális gerincen mért csontsűrűség csökkenéséhez vezet, mely hatás független a szérum-dehidroepiandroszteron-szulfát-szinttől.

  • Kitada, M., Kamataki, T., Itahashi, K. és mtsai: P-450 HFLa, a form of cytochrome P-450 purified from human fetal livers, is the 16 alpha-hydroxylase of dehydroepiandrosterone 3-sulfate. J. Biol. Chem., 1987, 262 , 13534–13537.

    Itahashi K. , 'P-450 HFLa, a form of cytochrome P-450 purified from human fetal livers, is the 16 alpha-hydroxylase of dehydroepiandrosterone 3-sulfate ' (1987 ) 262 J. Biol. Chem. : 13534 -13537.

    • Search Google Scholar
  • Gonzalez, F. J.: The molecular biology of cytochrome P450s. Pharmacol. Rev., 1988, 40 , 243–288.

    Gonzalez F. J. , 'The molecular biology of cytochrome P450s ' (1988 ) 40 Pharmacol. Rev. : 243 -288.

    • Search Google Scholar
  • Shimada, T., Yamazaki, H., Mimura, M. és mtsai: Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. J. Pharmacol. Exp. Ther., 1994, 270 , 414–423.

    Mimura M. , 'Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians ' (1994 ) 270 J. Pharmacol. Exp. Ther. : 414 -423.

    • Search Google Scholar
  • Brooks, B. A., McBride, O. W., Dolphin, C. T. és mtsai: The gene CYP3 encoding P450pcn1 (nifedipine oxidase) is tightly linked to the gene COL1A2 encoding collagen type 1 alpha on 7q21-q22.1. Am. J. Hum. Genet., 1988, 43 , 280–284.

    Dolphin C. T. , 'The gene CYP3 encoding P450pcn1 (nifedipine oxidase) is tightly linked to the gene COL1A2 encoding collagen type 1 alpha on 7q21-q22.1 ' (1988 ) 43 Am. J. Hum. Genet. : 280 -284.

    • Search Google Scholar
  • Molowa, D. T., Schuetz, E. G., Wrighton, S. A. és mtsai: Complete cDNA sequence of a cytochrome P-450 inducible by glucocorticoids in human liver. Proc. Natl. Acad. Sci. USA, 1986, 83 , 5311–5315.

    Wrighton S. A. , 'Complete cDNA sequence of a cytochrome P-450 inducible by glucocorticoids in human liver ' (1986 ) 83 Proc. Natl. Acad. Sci. USA : 5311 -5315.

    • Search Google Scholar
  • Aoyama, T., Yamano, S., Waxman, D. J. és mtsai: Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine. J. Biol. Chem., 1989, 264 , 10388–10395.

    Waxman D. J. , 'Cytochrome P-450 hPCN3, a novel cytochrome P-450 IIIA gene product that is differentially expressed in adult human liver. cDNA and deduced amino acid sequence and distinct specificities of cDNA-expressed hPCN1 and hPCN3 for the metabolism of steroid hormones and cyclosporine ' (1989 ) 264 J. Biol. Chem. : 10388 -10395.

    • Search Google Scholar
  • Kitada, M., Kamataki, T., Itahashi, K. és mtsai: Purification and properties of cytochrome P-450 from homogenates of human fetal livers. Arch. Biochem. Biophys., 1985, 241 , 275–280.

    Itahashi K. , 'Purification and properties of cytochrome P-450 from homogenates of human fetal livers ' (1985 ) 241 Arch. Biochem. Biophys. : 275 -280.

    • Search Google Scholar
  • Westlind, A., Malmebo, S., Johansson, I. és mtsai: Cloning and tissue distribution of a novel human cytochrome p450 of the CYP3A subfamily, CYP3A43. Biochem. Biophys. Res. Commun., 2001, 281 , 1349–1355.

    Johansson I. , 'Cloning and tissue distribution of a novel human cytochrome p450 of the CYP3A subfamily, CYP3A43 ' (2001 ) 281 Biochem. Biophys. Res. Commun. : 1349 -1355.

    • Search Google Scholar
  • Greuet, J., Pichard, L., Bonfils, C. és mtsai: The fetal specific gene CYP3A7 is inducible by rifampicin in adult human hepatocytes in primary culture. Biochem. Biophys. Res. Commun., 1996, 225 , 689–694.

    Bonfils C. , 'The fetal specific gene CYP3A7 is inducible by rifampicin in adult human hepatocytes in primary culture ' (1996 ) 225 Biochem. Biophys. Res. Commun. : 689 -694.

    • Search Google Scholar
  • Kuehl, P., Zhang, J., Lin, Y. és mtsai: Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression. Nat. Genet., 2001, 27 , 383–391.

    Lin Y. , 'Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression ' (2001 ) 27 Nat. Genet. : 383 -391.

    • Search Google Scholar
  • Lee, A. J., Cai, M. X., Thomas, P. E. és mtsai: Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms. Endocrinology, 2003, 144 , 3382–3398.

    Thomas P. E. , 'Characterization of the oxidative metabolites of 17beta-estradiol and estrone formed by 15 selectively expressed human cytochrome p450 isoforms ' (2003 ) 144 Endocrinology : 3382 -3398.

    • Search Google Scholar
  • Kitada, M., Kamataki, T., Itahashi, K. és mtsai: Significance of cytochrome P-450 (P-450 HFLa) of human fetal livers in the steroid and drug oxidations. Biochem. Pharmacol., 1987, 36 , 453–456.

    Itahashi K. , 'Significance of cytochrome P-450 (P-450 HFLa) of human fetal livers in the steroid and drug oxidations ' (1987 ) 36 Biochem. Pharmacol. : 453 -456.

    • Search Google Scholar
  • Smit, P., van Schaik, R. H., van der Werf, M. és mtsai: A common polymorphism in the CYP3A7 gene is associated with a nearly 50% reduction in serum dehydroepiandrosterone sulfate levels. J. Clin. Endocrinol. Metab., 2005, 90 , 5313–5316.

    Werf M. , 'A common polymorphism in the CYP3A7 gene is associated with a nearly 50% reduction in serum dehydroepiandrosterone sulfate levels ' (2005 ) 90 J. Clin. Endocrinol. Metab. : 5313 -5316.

    • Search Google Scholar
  • Hammer, F., Subtil, S., Lux, P. és mtsai: No evidence for hepatic conversion of dehydroepiandrosterone (DHEA) sulfate to DHEA: In vivo and in vitro studies. J. Clin. Endocrinol. Metab., 2005, 90 , 3600–3605.

    Lux P. , 'No evidence for hepatic conversion of dehydroepiandrosterone (DHEA) sulfate to DHEA: In vivo and in vitro studies ' (2005 ) 90 J. Clin. Endocrinol. Metab. : 3600 -3605.

    • Search Google Scholar
  • Haden, S. T., Glowacki, J., Hurwitz, S. és mtsai: Effects of age on serum dehydroepiandrosterone sulfate, IGF-I, and IL-6 levels in women. Calcif. Tissue Int., 2000, 66 , 414–418.

    Hurwitz S. , 'Effects of age on serum dehydroepiandrosterone sulfate, IGF-I, and IL-6 levels in women ' (2000 ) 66 Calcif. Tissue Int. : 414 -418.

    • Search Google Scholar
  • Koch, I., Weil, R., Wolbold, R. és mtsai: Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA. Drug Metab. Dispos., 2002, 30 , 1108–1114.

    Wolbold R. , 'Interindividual variability and tissue-specificity in the expression of cytochrome P450 3A mRNA ' (2002 ) 30 Drug Metab. Dispos. : 1108 -1114.

    • Search Google Scholar
  • Nishimura, M., Yaguti, H., Yoshitsugu, H. és mtsai: Tissue distribution of mRNA expression of human cytochrome P450 isoforms assessed by high-sensitivity real-time reverse transcription PCR. J. Pharm. Soc. Jap., 2003, 123 , 369–375.

    Yoshitsugu H. , 'Tissue distribution of mRNA expression of human cytochrome P450 isoforms assessed by high-sensitivity real-time reverse transcription PCR ' (2003 ) 123 J. Pharm. Soc. Jap. : 369 -375.

    • Search Google Scholar
  • Downie, D., McFadyen, M. C., Rooney, P. H. és mtsai: Profiling cytochrome P450 expression in ovarian cancer: Identification of prognostic markers. Clin. Cancer Res., 2005, 11 , 7369–7375.

    Rooney P. H. , 'Profiling cytochrome P450 expression in ovarian cancer: Identification of prognostic markers ' (2005 ) 11 Clin. Cancer Res. : 7369 -7375.

    • Search Google Scholar
  • Földes J., Lakatos P., Zsadányi J. és mtsa: Decreased serum IGF-I and dehydroepiandrosterone sulphate may be risk factors for the development of reduced bone mass in postmenopausal women with endogenous subclinical hyperthyroidism. Eur. J. Endocrinol., 1997, 136 , 277–281.

    Zsadányi J. , 'Decreased serum IGF-I and dehydroepiandrosterone sulphate may be risk factors for the development of reduced bone mass in postmenopausal women with endogenous subclinical hyperthyroidism ' (1997 ) 136 Eur. J. Endocrinol. : 277 -281.

    • Search Google Scholar